Published ahead of print on August 28, 2002, doi:10.1164/rccm.200204-345OC
Am. J. Respir. Crit. Care Med., Volume 166, Number 10, November 2002, 1396-1402
A more recent version of this article appeared on November 15, 2002
Submitted on April 18, 2002
Accepted on August 23, 2002
Characterization of high altitude pulmonary hypertension in the Kyrgyz: Association with ACE genotype
Almaz A Aldashev1, Akpay S Sarybaev1, Akyl S Sydykov1, Bolot B Kalmyrzaev1, Elena V Kim1, Lira B Mamanova1, Rashid Maripov1, Baktybek K Kojonazarov1, Mirsaid M Mirrakhimov1, Martin R Wilkins2, and Nicholas W Morrell3*
1 Laboratory of Molecular Biology, National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan,
2 Section on Clinical Pharmacology, Imperial College School of Medicine, London, United Kingdom,
3 Department of Medicine, University of Cambridge, Cambridge, United Kingdom
* To whom correspondence should be addressed. E-mail: nwm23{at}cam.ac.uk.
Previous studies have suggested a genetic component to the susceptibility to hypoxia-induced pulmonary hypertension. Thus we estimated the prevalence of high altitude pulmonary hypertension (HAPH) in a Kyrgyz population and whether the insertion/deletion (I/D) polymorphism of the ACE gene associates with HAPH. An electrocardiographic survey of 741 highlanders demonstrated ECG signs of cor pulmonale in 14% of subjects. Pulmonary artery hemodynamics measured in an independent group of 136 male highlanders with symptoms at altitude, revealed established pulmonary hypertension (MPAP 25mmHg) in 20%. However, 26% of the normal subjects demonstrated an exaggerated response ( 2-fold increase in MPAP) to inhalation of 11% oxygen, and were classified as hyper-responsive. 10 year follow up of this group revealed increases in the MPAP, but not in normals. Comparison of ACE I/D genotypes in the catheterized group revealed a 3-fold higher frequency of the I/I genotype in highlanders with HAPH, compared with normal highlanders ( 11.59, p=0.003). In addition, MPAP was higher in highlanders with the I/I (26.9±4.0mmHg) compared with the I/D (20.6±1.2mmHg, or the D/D genotype (18.3±0.9mmHg) (P<0.05). We conclude that HAPH is associated with ACE I/D genotype amongst Kyrgyz highlanders and the development of HAPH in this population may be predicted by hyper-responsiveness to acute hypoxia.
Key words: pulmonary hypertension, hypoxia, angiotensin converting enzyme,altitude
This article has been cited by other articles:

|
 |

|
 |
 
R. D. Machado, O. Eickelberg, C. G. Elliott, M. W. Geraci, M. Hanaoka, J. E. Loyd, J. H. Newman, J. A. Phillips III, F. Soubrier, R. C. Trembath, et al.
Genetics and genomics of pulmonary arterial hypertension.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1 Suppl):
S32 - S42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X-Q Xu and Z-C. Jing
High-altitude pulmonary hypertension
Eur. Respir. Rev.,
March 1, 2009;
18(111):
13 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Butrous, H. A. Ghofrani, and F. Grimminger
Pulmonary Vascular Disease in the Developing World
Circulation,
October 21, 2008;
118(17):
1758 - 1766.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. G. DeMarco, J. Habibi, A. T. Whaley-Connell, R. I. Schneider, R. L. Heller, J. P. Bosanquet, M. R. Hayden, K. Delcour, S. A. Cooper, B. T. Andresen, et al.
Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat
Am J Physiol Heart Circ Physiol,
June 1, 2008;
294(6):
H2659 - H2668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Luks and E. R. Swenson
Travel to high altitude with pre-existing lung disease
Eur. Respir. J.,
April 1, 2007;
29(4):
770 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Penaloza and J. Arias-Stella
The Heart and Pulmonary Circulation at High Altitudes: Healthy Highlanders and Chronic Mountain Sickness
Circulation,
March 6, 2007;
115(9):
1132 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bousquet, R. Dahl, and N. Khaltaev
Global Alliance against Chronic Respiratory Diseases
Eur. Respir. J.,
February 1, 2007;
29(2):
233 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Kojonazarov, B. Z. Imanov, T. A. Amatov, M. M. Mirrakhimov, R. Naeije, M. R. Wilkins, and A. A. Aldashev
Noninvasive and invasive evaluation of pulmonary arterial pressure in highlanders
Eur. Respir. J.,
February 1, 2007;
29(2):
352 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A A Aldashev, B K Kojonazarov, T A Amatov, T M Sooronbaev, M M Mirrakhimov, N W Morrell, J Wharton, and M R Wilkins
Phosphodiesterase type 5 and high altitude pulmonary hypertension
Thorax,
August 1, 2005;
60(8):
683 - 687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J.,
June 1, 2005;
25(6):
1084 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Humbert, O. Sitbon, and G. Simonneau
Treatment of Pulmonary Arterial Hypertension
N. Engl. J. Med.,
September 30, 2004;
351(14):
1425 - 1436.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hotta, M. Hanaoka, Y. Droma, Y. Katsuyama, M. Ota, and T. Kobayashi
Polymorphisms of Renin-Angiotensin System Genes With High-Altitude Pulmonary Edema in Japanese Subjects
Chest,
September 1, 2004;
126(3):
825 - 830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Y. Lam, M.-L. Fung, and P. S. Leung
Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body
J Appl Physiol,
February 1, 2004;
96(2):
809 - 813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Duke
Hypoxaemia in developing countries
Arch. Dis. Child.,
April 1, 2003;
88(4):
365 - 365.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
356 - 370.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|